This group focuses on the aetiology and natural history of asthma/allergic disease, idiopathic pulmonary fibrosis, lung cancer, cystic fibrosis and hereditary telangiectasia and delivery of care for people with lung cancer, using e-health databases and collection of original data.
Much of the research is conducted alongside the Nottingham Respiratory Research Unit.
Major contributions to the evidence base include:
Work on lung cancer care pathways and variation in access to treatment has guided national service planning.
Andrew Fogarty
The University of Nottingham School of Medicine
email:email us